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Abstract
Background: Hypertension and atherosclerosis are bidirectionally related, while platelet count could serve as an
indicator of endothelial repair. Therefore, high platelet counts could be associated with hypertension by indicating
more intense endothelial repair activity. Furthermore, short stature has been shown to constitute a risk of atherosclerosis.
Since inflammation-related single-nucleotide polymorphism (SNP (rs3782886)) is reportedly associated with myocardial
infarction and short stature, rs3782886 could be associated with a high platelet count and thus more intense endothelial
repair activity.
Methods: We conducted a cross-sectional study of 988 elderly Japanese who participated in a general health check-up.
Short stature was defined as a height of at or under the 25th percentile of the study population, and high platelet count
as the highest tertiles of the platelet levels.
Results: High platelet counts were found to be independently and positively associated with hypertension
while rs3782886 was independently associated with high platelet levels and short stature. The classical
cardiovascular risk factor-adjusted odds ratio (OR) and 95% confidence interval (CI) of high platelet count for
hypertension was 1.34 (1.02, 1.77). With non-minor homo of the rs3782886 as the reference group, the adjusted OR
and 95% CI for high platelet count and short stature of minor home were 2.40 (1.30, 4.42) and 2.21 (1.16,
4.21), respectively.
Conclusion: SNP (rs3782886) was shown to be associated with high platelet count and short stature. This
result partly explains how a genetic factor can influence the impact of height on endothelial repair.
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Background
Hypertension is known as a major risk factor of stroke
for Japanese [1] while short stature is well known as a
Japanese characteristic. Furthermore, short stature has
been reported to have an independent association with
hypertension [2], carotid atherosclerosis [3], and inci-
dence of stroke [4]. However, previous studies of ours
indicate that the presence of carotid atherosclerosis
cannot explain the risk of stroke associated with short
stature [3, 4].
Recently, hematopoietic activity has been revealed to
be closely associated with vascular maintenance activity
(endothelial repair activity [5–8]). Short stature has been
shown to be associated with lower capacity for
hematopoietic activity [9, 10] and with anemia [11] pos-
sibly due to the fact that height indicates the absolute
volume of total bone marrow. Higher capacity for
hematopoietic activity (high hemoglobin level) has been
found to be positively associated with atherosclerosis [6,
7] and hypertension [8, 12].
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Those studies raise issues emerging from paradoxical
findings for short stature as a risk for anemia, hyperten-
sion, carotid atherosclerosis, and incidence of stroke.
Since atherosclerosis results from aggressive endothelial
repair, the findings of these studies indicate that the risk of
stroke in people with short stature might be associated
with low endothelial repair activity (low hematopoietic
activity).
Single-nucleotide polymorphism (SNP) (rs3782886) in
breast cancer suppressor BRCA1-related associated pro-
tein (BRAP) is reportedly associated with risk of myocar-
dial infarction [13], while SNP (rs3782886) is also found
to be associated with short stature in a previous study
by us [14]. Another study reported that BRAP activates
inflammatory cascades and increases the risk of carotid
atherosclerosis [15] but is not associated with risk of
stroke [16]. Although an SNP (rs3782886) could be asso-
ciated with carotid atherosclerosis, these studies indicate
that it might also have a beneficial effect on stroke pre-
vention by inducing endothelial repair in participants
with short stature; otherwise, these participants would
have high risks of hypertension [2], carotid atheroscler-
osis [3], and stroke [4].
Furthermore, platelet is known to contribute to endo-
thelial repair [17]. We previously showed that platelet
levels were positively associated with hypertension [18]
and that platelet count could serve as an indicator of
vascular repair (endothelial repair and developing ath-
erosclerosis) [19]. Since the association between hyper-
tension and atherosclerosis (increased arterial stiffness)
is bidirectional [20–22], high platelet levels, which are
associated with hypertension, can be expected to reflect
a higher activity of endothelial repair.
Since height is inversely associated with platelet count
in elderly men [23], clarification of the relationship of SNP
(rs3782886) with short stature and high platelet counts,
which are in turn associated with hypertension, should
provide us with an efficient tool to clarify the underlying
mechanism of the effect of height on endothelial repair.
We therefore hypothesized that hypertension is posi-
tively associated with a high platelet count, thus indicating
active endothelial repair. Moreover, that SNP (rs3782886)
is also associated with a high platelet count and short stat-
ure since it plays an important role in the activation of
endothelial repair in participants with short stature.
To elucidate those associations, we conducted a
cross-sectional study of 988 elderly Japanese participants
aged 60–89 years who participated in a general health
check-up in 2014 and 2015.
Methods
Study population
The total number of residents of Goto City aged 60–89
in 2015 was 16,176, based on an estimate by the
National Institute of Population and Social Security Re-
search in March 2013 [24].
The study population comprised 992 Japanese elderly
residents aged 60–89 years from the rural communities
of the Goto Islands in western Japan, who underwent
annual medical check-ups in 2014 and 2015 as recom-
mended by the Japanese government.
Participants without SNP data (n = 3) and without
blood pressure data (n = 1) were excluded, leaving 988
participants with a mean age of 72.6 years (standard de-
viation (SD), 7.3; range, 60–89) enrolled in the study.
Data collection and laboratory measurements
Trained interviewers obtained information on medical
history (lifestyle habit). Body weight and height were
measured with an automatic body composition analyzer
(BF-220; Tanita, Tokyo, Japan), and body mass index
(BMI; kg/m2) was calculated. Systolic and diastolic blood
pressure were recorded at rest. Blood samples were col-
lected in an EDTA-2 K tube, a siliconized tube, and so-
dium fluoride tube. The number of platelets in samples
from the EDTA-2 K tube was measured with an auto-
mated procedure at SRL, Inc. (Tokyo, Japan). Triglycer-
ides (TG) and serum creatinine were measured
enzymatically, while HDL cholesterol (HDLc) was mea-
sured with a direct method and hemoglobin A1c
(HbA1c) with the latex coagulation method. Genomic
DNA was extracted from 2ml of whole peripheral blood
by means of the Gene Prep Star NA-480 (Kurabo Indus-
tries Ltd., Osaka, Japan) and typed for SNP rs3782886
(BRAP on chromosome 12q24.12) by using the HybP-
robe method with LightCycler 480 (Roche Diagnos-
tics, Basel, Switzerland). Hypertension was defined as
systolic blood pressure ≥ 140mmHg and/or diastolic
blood pressure ≥ 90 mmHg. A high platelet level was
defined as the highest tertile (≥ 22.0 × 104/μL for men
and ≥ 24.2 × 104/μL for women) and short stature as a
height level at or under the 25th percentile of the
study population (< 158.4 cm for men and < 146.4 cm
for women) as in a previous study by us [3, 14].
Statistical analysis
Characteristics of the study population stratified by
platelet level and SNP (rs3782886) genotype were
expressed as mean ± standard deviation. A trend test
was performed with analysis of variance (ANOVA) for
continuous values, and chi-squared test was used for de-
termining proportions.
Logistic regression models were also used to calculate
odds ratios (ORs) and 95% confidence intervals (CIs) in
order to determine the influence of platelet level on
hypertension. In addition, ORs and 95% CIs were calcu-
lated by using a logistic regression model to determine
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the influence of SNP (rs3782886) on high platelet
counts, hypertension, and short stature.
Adjustments for confounding factors were made by
using two models. In the first model (model 1), adjust-
ment was made only for age and sex. Alcohol consump-
tion has been shown to be positively associated with
height in previous studies [3, 4, 25], and white blood cell
count to be a factor that is influenced by smoking status
[26] while height is inversely associated with high white
blood cell count [25]. BMI could be positively associated
with endothelial repair (CD34-positive cell count) [8, 18,
27–29] while height is positively associated with
CD34-positive cell count in participants with systolic
hypertension [30]. Another study reported the identifica-
tion of a primary association between a genetically
determined short stature and an increased risk of cardio-
vascular disease which may be partly explained by the
association between short stature and adverse lipid pro-
file [31]. In one of our studies, we reported that the ac-
tivity of endothelial repair (CD34-positive cells) might
influence the association between blood pressure and
TG [29] and HDLc [28]. HbA1c has also been found to
be associated with atherosclerosis [32, 33]. All these fac-
tors are well-known classical cardiovascular risk factors.
Furthermore, renal function is reportedly associated with
SNP (rs3782886) [34], endothelial repair (CD34-positive
cells) [35], anemia [36], and incidence of stroke [37]. We
therefore added serum creatinine as a confounding fac-
tor to the aforementioned classical cardiovascular risk
factors for the present analysis. Therefore, the second
model (model 2) included other, possibly confounding,
factors, namely, BMI (kg/m2), (systolic blood pressure
(mmHg), which was not applicable to the analysis of the
associations between platelet count and hypertension
nor to the associations between SNP (rs3782886) and
hypertension), alcohol consumption (never-drinker,
former drinker, current drinker [< 23 g/week, 23–46 g/
week, 47–68 g/week, ≥ 69 g/week]), smoking status
(never-smoker, former smoker, current smoker), HDLc
(mg/dL), TG (mg/dL), HbA1C (%), and serum creatin-
ine (mg/dL).
For the sensitivity analysis, we repeated our investiga-
tions with sex-specific models.
All statistical analyses were performed with the SAS
system for Windows (version 9.4; SAS Inc., Cary,
NC). Values of < 0.05 were regarded as being statisti-
cally significant.
Results
Characteristics of study population in relation to platelet
levels
Characteristics of the study population in relation to
platelet levels are shown in Table 1. The current smoker
group showed positive associations with platelet levels
while age and serum creatinine were inversely associated
with platelet levels.
Association between platelet levels and hypertension
Table 2 shows ORs and 95% CIs for hypertension in re-
lation to platelet count. Independent of known cardio-
vascular risk factors, the high platelet level group
showed significantly higher OR for hypertension com-
pared with the reference group of non-high platelet
levels (T1 and T2); the adjusted OR and 95% CI for
hypertension was 1.34 (1.02, 1.77).
Table 1 Characteristics of the study population in relation to platelet levels
Platelet levels P
T1 (low) T2 T3 (high)
No. of participants 332 327 329
Age, years 73.6 ± 7.1 72.4 ± 7.3 71.6 ± 7.4 0.003
Gender of men, % 37.0 37.6 37.4 0.989
Body mass index (BMI), kg/m2 23.1 ± 3.6 23.3 ± 3.1 23.2 ± 3.2 0.776
Systolic blood pressure, mmHg 139 ± 18 139 ± 17 141 ± 19 0.179
Diastolic blood pressure, mmHg 80 ± 11 81 ± 11 82 ± 11 0.080
Current drinker, % 22.6 23.5 27.4 0.323
Current smoker, % 3.3 6.4 8.8 0.013
Serum triglycerides (TG), mg/dL 93 ± 54 108 ± 63 106 ± 53 0.001
Serum HDL cholesterol (HDLc), mg/dL 59 ± 16 60 ± 18 60 ± 15 0.565
Hemoglobin A1c (HbA1c), % 5.7 ± 0.5 5.6 ± 0.4 5.8 ± 0.6 0.002
Serum creatinine, mg/dL 0.78 ± 0.22 0.75 ± 0.19 0.73 ± 0.18 0.003
Platelets, × 104/μL 16.6 ± 2.7 21.5 ± 1.4 27.7 ± 5.1 < 0.001
Values: mean ± standard deviation. Platelet levels for men are < 18.7 × 104/μL for T1, 18.7–21.9 × 104/μL for T2, and ≥ 22.0 × 104/μL for T3, for women are < 20.3 ×
104/μL for T1, 20.3–24.1 × 104/μL for T2, and ≥ 24.2 × 104/μL for T3
Shimizu et al. Environmental Health and Preventive Medicine           (2019) 24:26 Page 3 of 8
Characteristics of the study population by genotype of
SNPs (rs3782886)
Characteristics of the study population by genotype of
SNPs (rs3782886) are shown in Table 3. Of the 988 elderly
Japanese participants, 609 were major homogeneous (A/
A), 332 were heterogeneous (A/G), and 47 were minor
homogeneous (G/G). This SNP was in Hardy-Weinberg
equilibrium. Current drinker was inversely significantly as-
sociated with minor allele frequency (G) while platelet
level showed a significantly positive association.
Associations between rs3782886 genotype and high
platelet levels
Table 4 shows the associations between genotype and
high platelet levels. For model 1 with major homogeneity
(A/A) as the reference group, no significant association
was observed for heterogeneity (A/G), while a significant
association was observed for minor homogeneity (G/G).
When we made further adjustment for other known
cardiovascular risk factors, those associations with the
reference group became slightly stronger and the statis-
tical value became significant for heterogeneity.
Associations between the rs3782886 genotype and short
stature
Table 5 shows the associations between genotype and
short stature. With major homogeneity (A/A) as the ref-
erence group, no significant association was observed
for heterogeneity (A/G), while a significant association
was observed for minor homogeneity (G/G). However, a
comparison of the two categories non-minor homogen-
eity and minor homogeneity showed a significant
association.
Associations between rs3782886 genotype and
hypertension
No significant associations between genotype and hyper-
tension were observed (Table 6).
Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for hypertension in relation to platelet levels
Platelet levels P for
trend
1 SD increment of
plateletT1 (low) T2 T3 (high)
No. at risk 332 327 329
No. of cases (percentage) 160 (48.2) 170 (52.0) 185 (56.2)
Model 1 1.00 1.22 (0.89, 1.66) 1.49 (1.09, 2.04) 0.012 1.16 (1.02, 1.33)
1.00 1.35 (1.03, 1.77) 0.029
Model 2 1.00 1.20 (0.87, 1.64) 1.47 (1.07, 2.03) 0.018 1.15 (1.01, 1.32)
1.00 1.34 (1.02, 1.77) 0.036
Model 1 adjusted only for sex and age. Model 2 further adjusted for body mass index, alcohol consumption (never-drinker, former drinker, current drinker [< 23 g/
week, 23–45 g/week, 46–68 g/week, ≥ 69 g/week]), smoking status (never-smoker, former smoker, current smoker), HDL cholesterol, triglycerides, HbA1C, and
serum creatinine. Hypertension is defined as systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg. Platelet levels for men are < 18.7 ×
104/μL for T1, 18.7–21.9 × 104/μL for T2, and ≥ 22.0 × 104/μL for T3, for women are < 20.3 × 104/μL for T1, 20.3–24.1 × 104/μL for T2, and ≥ 24.2 × 104/μL for T3. 1
standard deviation (SD) increments of platelet are 6.23 × 104/μL for men and 5.26 × 104/μL for women
Table 3 Characteristics of the study population by genotype of rs3782886
rs3782886 P
Major homo (A/A) Hetero type (A/G) Minor homo (G/G)
No. of participants 609 332 47
Age, years 72.1 ± 7.2 73.2 ± 7.4 72.8 ± 7.1 0.089
Gender of men, % 36.3 40.1 31.9 0.382
Body mass index (BMI), kg/m2 23.1 ± 3.2 23.4 ± 3.5 23.0 ± 3.3 0.274
Systolic blood pressure, mmHg 140 ± 18 140 ± 18 139 ± 19 0.990
Diastolic blood pressure, mmHg 82 ± 11 80 ± 11 81 ± 11 0.134
Current drinker, % 32.7 13.0 0.0 < 0.001
Current smoker, % 7.2 4.8 2.1 0.171
Serum triglycerides (TG), mg/dL 102 ± 60 103 ± 53 100 ± 39 0.941
Serum HDL cholesterol (HDLc), mg/dL 61 ± 17 58 ± 15 60 ± 18 0.066
Hemoglobin A1c (HbA1c), % 5.7 ± 0.5 5.7 ± 0.5 5.7 ± 0.6 0.722
Serum creatinine, mg/dL 0.75 ± 0.20 0.77 ± 0.19 0.75 ± 0.20 0.149
Platelets, × 104/μL 21.5 ± 4.9 22.4 ± 6.9 23.2 ± 4.9 0.019
Values: mean ± standard deviation
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The sensitivity analysis showed similar associations to
those obtained for the main results.
Discussion
The major findings of the present study with elderly Jap-
anese participants are that a high platelet level is posi-
tively associated with hypertension for elderly Japanese
participants and that inflammation-related SNP
(rs3782886) is significantly associated with a high plate-
let level and short stature.
Recently, platelets have been revealed to play a major
role in inflammation, as well as to be important as an
initial activator for the development of atherosclerotic
lesions [38]. Even though development of atherosclerosis
is only one aspect of endothelial repair, the association
between hypertension and endothelial dysfunction (ath-
erosclerosis) is bidirectional: hypertension induces in-
creased arterial stiffness and vice versa [20–22]. Since
our study presented here discovered a significant posi-
tive association between high platelet levels and hyper-
tension, the former can be assumed to indicate a greater
level of endothelial repair activity. In one of our previous
studies, a high platelet count was found to be positively
associated with hypertension in elderly men [18]. We
also found that platelet levels are positively associated
with carotid intima-media thickness (CIMT) in elderly
hypertensive men [18, 19]. Those findings also support
our hypothesis that a high platelet count is likely to indi-
cate a higher level of endothelial repair activity. In
addition, SNP (rs3782886) is known to be located in the
BRAP gene on chromosome 12q24 and that a higher ex-
pression of the BRAP minor allele is associated with an
increased risk of atherosclerosis by heightening the de-
gree of inflammation through activation of the NF-κB
protein [15, 39]. Since activation of the NF-κB pathway
also could promote platelet activation protein [40], our
finding that SNP (rs3782886) is significantly associated
with high platelet levels is likely to indicate that the gen-
etic factor might influence the level of endothelial repair
activity.
Furthermore, short stature has been shown to consti-
tute an inflammatory risk for elderly Japanese men as
shown by a high white blood cell count [25]. Moreover,
SNPs (rs3782886) were shown to be associated with
short stature in a previous study by us [14]. SNPs
(rs3782886) were also found to be significantly
Table 4 Odds ratios (ORs) and 95% confidence intervals (CIs) for high platelet in relation to rs3782886 genotype
rs3782886 P for
trendNon-minor homo Minor homo
(G/G)Major homo (A/A) Hetero (A/G)
No. at risk 609 332 47
No. of cases (percentage) 186 (30.5) 119 (35.8) 24 (51.1)
Model 1 1.00 1.31 (0.99, 1.74) 2.44 (1.34, 4.45) 0.002
1.00 2.21 (1.22, 3.99) 0.009
Model 2 1.00 1.49 (1.10, 2.01) 2.86 (1.52, 5.37) < 0.001
1.00 2.40 (1.30, 4.42) 0.005
Model 1 adjusted only for sex and age. Model 2 further adjusted for body mass index, systolic blood pressure, alcohol consumption (never-drinker, former drinker,
current drinker [< 23 g/week, 23–45 g/week, 46–68 g/week, ≥ 69 g/week]), smoking status (never-smoker, former smoker, current smoker), HDL cholesterol,
triglycerides, HbA1C, and serum creatinine. The high platelet level is defined as the highest tertiles of platelets levels (≥ 22.0 × 104/μL for men and ≥ 24.2 × 104/μL
for women)
Table 5 Odds ratios (ORs) and 95% confidence intervals (CIs) for short stature in relation to rs3782886 genotype
rs3782886 P for
trendNon-minor homo Minor homo
(G/G)Major homo (A/A) Hetero (A/G)
No. at risk 609 332 47
No. of cases (percentage) 132 (21.7) 94 (28.3) 19 (40.4)
Model 1 1.00 1.32 (0.96, 1.83) 2.55 (1.33, 4.89) 0.004
1.00 2.30 (1.21, 4.36) 0.011
Model 2 1.00 1.33 (0.94, 1.87) 2.51 (1.29, 4.89) 0.006
1.00 2.21 (1.16, 4.21) 0.016
Model 1 adjusted only for sex and age. Model 2 further adjusted for body mass index, systolic blood pressure, alcohol consumption (never-drinker, former drinker,
current drinker [< 23 g/week, 23–45 g/week, 46–68 g/week, ≥ 69 g/week]), smoking status (never-smoker, former smoker, current smoker), HDL cholesterol,
triglycerides, HbA1C, and serum creatinine. Short stature is defined as a height level at or under the 25th percentile of the study population (< 158.4 cm for men
and
< 146.4 cm for women)
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associated with a high platelet count and short stature in
the current study, indicating that the genetic factor may
at least partly influence the risk of inflammatory changes
which induce endothelial repair in participants with short
stature. Another study by us of elderly men also supports
the notion of this mechanism. In this study, we showed
that platelet level is positively associated with CIMT and
circulating endothelial progenitor cells (CD34-positive
cells) while height is inversely associated with platelet
count for participants with high hemoglobin levels [23].
The inverse association between height and hyperten-
sion which is reported in a Chinese study [2] is probably
due to a reduced anti-oxidative stress capacity [20, 21,
41] since short stature is associated with lower
hematopoiesis activity [9, 10] and higher risk of anemia
[11]. Lower endothelial repair capacity which is a charac-
teristic of short stature [23, 30] also might induce hyper-
tension because of its reduced ability to compensate for
blockage of the blood flow. Moreover, hypertension is a
well-known major risk factor for stroke in Japanese [1]
who are known to be characterized by short stature and
low BMI. Since we reported in a previous study that
height was inversely associated with the incidence of
stroke only in participants with low BMI (< 23 kg/m2)
[4], and that carotid atherosclerosis was inversely associ-
ated with height only in participants with high BMI (≥
25 kg/m2) [3], carotid atherosclerosis alone could not ex-
plain the risk of stroke for Japanese with short stature.
In fact, reduced capability for endothelial repair [23, 30]
and hypertension [2] characteristic of short stature
might perform an important role in the incidence of
stroke for participants with short stature. Since BRAP is
reportedly associated with atherosclerosis [15] but not
associated with stroke [16] and SNPs (rs3782886) are as-
sociated with short stature [14], SNP (rs3782886) might
perform an import function for the prevention of stroke
for participants with short stature by stimulating endo-
thelial repair. In the present study, even though SNP
(rs3782886) was found to be associated with a high
platelet count, which is related to hypertension, no
significant association between SNP (rs3782886) and
hypertension was observed, which partly supports the
aforementioned mechanisms because adequate endothe-
lial maintenance was performed predominantly for nor-
mal body weight participants. To clarify those
mechanisms, further study is needed with a larger popu-
lation which makes it possible to perform a BMI
status-specific analysis of the relationship between SNP
(rs3782886) and hypertension.
From the anthropological point of view, an extensive
presence of SNP (rs3782886) should have some benefi-
cial effects on life activities rather than disadvantages.
Even though SNP (rs3782886) is reportedly associated
with myocardial infarction [13], the findings presented
here indicate that the beneficial effect of SNP
(rs3782886) is a high endothelial repair activity among
participants with short stature whose endothelial repair
activity is low [9, 10, 23].
The present findings are efficient for clarifying the
mechanism underlying the association between height
and endothelial repair as they indicate that genetic factors
could at least partly influence this association. In addition,
the present findings also clarify the reason why the exten-
sive presence of inflammatory disadvantage-associated
SNP (rs3782886) [13, 15] could be established among the
general Japanese population.
Possible limitations of this study warrant consider-
ation. First, because creatinine clearance data were not
available and estimated glomerular filtration rate (GFR)
is not an effective tool for evaluating kidney function for
a comparison of associations with various body heights
[3, 4, 9, 10, 25, 42], we could not perform an analysis ad-
justed for accurate renal function. However, our study
showed that associations, such as between high platelet
and hypertension, SNPs (rs3782886) and high platelet
level, and SNPs (rs3782886) and short stature, remained
significant even after adjustment for serum creatinine.
Second, because this was a cross-sectional study, causal
Table 6 Odds ratios (ORs) and 95% confidence intervals (CIs) for hypertension in relation to rs3782886 genotype
rs3782886 P for
trendNon-minor homo Minor homo
(G/G)Major homo (A/A) Hetero (A/G)
No. at risk 609 332 47
No. of cases (percentage) 320 (52.5) 170 (51.2) 25 (53.2)
Model 1 1.00 0.91 (0.70, 1.20) 1.00 (0.55, 1.82) 0.652
1.00 1.03 (0.57, 1.87) 0.912
Model 2 1.00 0.93 (0.70, 1.23) 1.05 (0.57, 1.93) 0.324
1.00 1.08 (0.60, 1.98) 0.791
Model 1 adjusted only for sex and age. Model 2 further adjusted for body mass index, alcohol consumption (never-drinker, former drinker, current drinker [< 23 g/
week, 23–45 g/week, 46–68 g/week, ≥ 69 g/week]), smoking status (never-smoker, former smoker, current smoker), HDL cholesterol, triglycerides, HbA1C, and
serum creatinine. Hypertension is defined as systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg
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relationships were not able to be established. Further-
more, because our study used elderly Japanese who par-
ticipated in a general health check-up, selection bias
arising from this kind of study is unavoidable.
Conclusion
In conclusion, there is a significant and positive associ-
ation between high platelet count and hypertension, and
SNPs (rs3782886) were shown to be associated with high
platelet count and short stature. These results partly ex-
plain how a genetic factor can influence the impact of
height on endothelial repair.
Abbreviations
ANOVA: Analysis of variance; BMI: Body mass index; BRAP: BRCA1-related
associated protein; CI: Confidence interval; CIMT: Carotid intima-media thick-
ness; GFR: Glomerular filtration rate; HbA1c: Hemoglobin A1c; HDLc: HDL
cholesterol; OR: Odds ratio; SD: Standard deviation; SNP: Single-nucleotide
polymorphism; TG: Triglycerides
Acknowledgements
We are grateful to staff from Goto City Hall for their outstanding support.
Funding
This study was supported by Grants-in-Aids for Scientific Research from the
Japan Society for the Promotion of Sciences (No.18 K06448, No.17H03740).
Availability of data and materials
The datasets generated during and/or analyzed during the current study are
not publicly available due to ethical consideration but are available from the
corresponding author on reasonable request.
Authors’ contributions
YS designed the study and performed the statistical analyses, interpreted the
data, and drafted the manuscript or revised it. YS, HY, YN, JK, MN, SF, MT, S-
YK, and KA assisted with the design of the study, were involved in the data
collection, and checked the manuscript. HY, S-YK, and TM participated in the
study concept and checked the manuscript. TM was the general coordinator
and also designed the study. All authors read and approved the final
manuscript.
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in
accordance with the ethical standards of the institution research committee
and with the 1964 Helsinki declaration and its later amendments for
comparable ethical standards. The Ethics Committee for Human Use of
Nagasaki University obtained ethical approval. This study was approved
by the Ethics Committee of Nagasaki University Graduate School of
Biomedical Sciences (project registration number 14051404). Written
consent forms were available in Japanese to ensure comprehensive





The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Author details
1Department of Community Medicine, Nagasaki University Graduate School
of Biomedical Sciences, Nagasaki-shi, Sakamoto 1-12-4, Nagasaki 852-8523,
Japan. 2Department of Cardiovascular Disease Prevention, Osaka Center for
Cancer and Cardiovascular Disease Prevention, Osaka, Japan. 3Department of
General Medicine, Nagasaki University Hospital, Nagasaki, Japan. 4Department
of Island and Community Medicine, Nagasaki University Graduate School of
Biomedical Sciences, Nagasaki, Japan. 5Department of Immunology and
Rheumatology, Nagasaki University Graduate School of Biomedical Sciences,
Nagasaki, Japan. 6Department of Public Health, Nagasaki University Graduate
School of Biomedical Sciences, Nagasaki, Japan.
Received: 3 September 2018 Accepted: 9 April 2019
References
1. Kitamura A, Yamagishi K, Imano H, Kiyama M, Cui R, Ohira T, et al; CIRCS
Investigators. Impact of hypertension and subclinical organ damage on the
incidence of cardiovascular disease among Japanese residents at the
population and individual levels - The Circulatory Risk in Communities
Study (CIRCS). Circ J. 2017;81(7):1022–8.
2. Song L, Shen L, Li H, Liu B, Zheng X, Liang Y, et al. Height and prevalence
of hypertension in a middle-aged and older Chinese population. Sci Rep.
2016;6:39480.
3. Shimizu Y, Nakazato M, Sekita T, Kadota K, Arima K, Yamasaki H, et al.
Relationship between adult height and body weight and risk of carotid
atherosclerosis assessed in terms of carotid intima-media thickness: the
Nagasaki Islands study. J Physiol Anthropol. 2013;32:19.
4. Shimizu Y, Imano H, Ohira T, Kitamura A, Kiyama M, Okada T, et al; CIRCS
Investigators. Adult height and body mass index in relation to risk of total
stroke and its subtypes: the circulatory risk in communities study. J Stroke
Cerebrovasc Dis. 2014;23(4):667–74.
5. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, et al. Evidence for
circulating bone marrow-derived endothelial cells. Blood. 1998;92(2):362–7.
6. Shimizu Y, Kadota K, Nakazato M, Noguchi Y, Koyamatsu J, Yamanashi H, et
al. Hemoglobin as a possible biochemical index of hypertension-induced
vascular damage. J Physiol Anthropol. 2016;35:4.
7. Shimizu Y, Nakazato M, Sekita T, Kadota K, Yamasaki H, Takamura N, et al.
Association between hemoglobin levels and arterial stiffness for general
Japanese population in relation to body mass index status: the Nagasaki
Islands study. Geriatr Gerontol Int. 2014;14(4):811–8.
8. Shimizu Y, Sato S, Koyamatsu J, Yamanashi H, Nagayoshi M, Kadota K, et al.
Possible mechanism underlying the association between higher
hemoglobin level and hypertension in older Japanese men. Geriatr
Gerontol Int. 2017;17(12):2586–92.
9. Shimizu Y, Sato S, Koyamatsu J, Yamanashi H, Nagayoshi M, Kadota K, et al.
Height indicates hematopoietic capacity in elderly Japanese men. Aging
(Albany NY). 2016;8(10):2407–13.
10. Shimizu Y, Yamanashi H, Noguchi Y, Koyamatsu J, Nagayosi M, Kiyoura
K, et al. Association between height and circulating CD34-posistive cells
taken into account for the influence of enhanced production among
elderly Japanese men: a cross-sectional study. Aging (Albany NY). 2019;
11(2):663–72.
11. Shimizu Y, Nakazato M, Sekita T, Kadota K, Miura Y, Arima K, et al. Height
and drinking status in relation to risk of anemia in rural adult healthy
Japanese men: the Nagasaki Islands study. Aging Male. 2015;18(2):100–5.
12. Shimizu Y, Nakazato M, Sekita T, Kadota K, Arima K, Yamasaki H, et al.
Association between the hemoglobin levels and hypertension in relation to
the BMI status in a rural Japanese population: the Nagasaki Islands Study.
Intern Med. 2014;53(5):435–40.
13. Ozaki K, Sato H, Inoue K, Tsunoda T, Sakata Y, Mizuno H, et al. SNPs in BRAP
associated with risk of myocardial infarction in Asian populations. Nat
Genet. 2009;41(3):329–33.
14. Shimizu Y, Sato S, Noguchi Y, Koyamatsu J, Yamanashi H, Higashi M, et al.
Impact of single nucleotide polymorphism on short stature and reduced
tongue pressure among community-dwelling elderly Japanese participants:
a cross-sectional study. Environ Health Prev Med. 2017;22(1):62.
15. Liao YC, Wang YS, Guo YC, Ozaki K, Tanaka T, Lin HF, et al. BRAP activates
inflammatory cascades and increases the risk for carotid atherosclerosis. Mol
Med. 2011;17(9–10):1065–74.
16. Liao YC, Lin HF, Guo YC, Chen CH, Huang ZZ, Juo SH, et al. Lack of
association between a functional variant of the BRCA-1 related associated
protein (BRAP) gene and ischemic stroke. BMC Med Genet. 2013;14:17.
17. Stellos K, Langer H, Daub K, Schoenberger T, Gauss A, Geisler T, et al.
Platelet-derived stromal cell-derived factor-1 regulates adhesion and
Shimizu et al. Environmental Health and Preventive Medicine           (2019) 24:26 Page 7 of 8
promotes differentiation of human CD34+ cells to endothelial progenitor
cells. Circulation. 2008;117(2):206–15.
18. Shimizu Y, Sato S, Koyamatsu J, Yamanashi H, Nagayoshi M, Kadota K, et al.
Platelets and circulating CD34-positive cells as an indicator of the activity of
the vicious cycle between hypertension and endothelial dysfunction in
elderly Japanese men. Atherosclerosis. 2017;259:26–31.
19. Shimizu Y, Sato S, Koyamatsu J, Yamanashi H, Nagayoshi M, Kadota K, et al.
Platelets as an indicator of vascular repair in elderly Japanese men.
Oncotarget. 2016;7(29):44919–26.
20. Dohi Y. Hypertension and oxidative stress. Nagoya Med J. 2010;51(3):153–8.
[Article in Japanese].
21. Higashi Y, Sueda T, Yoshizumi M. Role of angiotensin II-related oxidative
stress and nitric oxide in endothelial function in hypertension. J Jpn Coll
Angiol. 2003;43:47–52 [Article in Japanese].
22. Nakamura S, Moriguchi A, Morishita R, Aoki M, Yo Y, Hayahsi S, et al. A novel
vascular modulator, hepatocyte growth factor (HGF), as a potential index of the
severity of hypertension. Biochem Biophys Res Commun. 1998;242(1):238–43.
23. Shimizu Y, Sato S, Koyamatsu J, Yamanashi H, Nagayoshi M, Kadota K,
et al. Possible mechanism underlying the association between height
and vascular remodeling in elderly Japanese men. Oncotarget. 2018;
9(8):7749–57.
24. National Institute of Population and Social Security Research [Home page
on the Internet]. Available from: http://www.ipss.go.jp/pp-shicyoson/j/
shicyoson13/3kekka/Municipalities.asp. [Cited 14 April 2019].
25. Shimizu Y, Yoshimine H, Nagayoshi M, Kadota K, Takahashi K, Izumino K, et
al. Short stature is an inflammatory disadvantage among middle-aged
Japanese men. Environ Health Prev Med. 2016;21(5):361–7.
26. Kawada T. Relationships between the smoking status and plasma
fibrinogen, white blood cell count and serum C-reactive protein in
Japanese workers. Diabetes Metab Syndr. 2015;9(3):180–2.
27. Shimizu Y, Sato S, Koyamatsu J, Yamanashi H, Nagayoshi M, Kawashiri SY, et al.
Hepatocyte growth factor and carotid intima-media thickness in relation to
circulating CD34-positive cell levels. Environ Health Prev Med. 2018;23(1):16.
28. Shimizu Y, Sato S, Koyamatsu J, Yamanashi H, Nagayoshi M, Kadota K, et al.
Association between high-density lipoprotein-cholesterol and hypertension
in relation to circulating CD34-positive cell levels. J Physiol Anthropol. 2017;
36(1):26.
29. Shimizu Y, Sato S, Noguchi Y, Koyamatsu J, Yamanashi H, Nagayoshi M, et
al. Triglycerides and blood pressure in relation to circulating CD34-positive
cell levels among community-dwelling elderly Japanese men: a cross-
sectional study. Environ Health Prev Med. 2017;22(1):77.
30. Shimizu Y, Sato S, Koyamatsu J, Yamanashi H, Nagayoshi M, Kadota K, et al.
Height is an indicator of vascular maintenance capacity in older men.
Geriatr Gerontol Int. 2017;17(10):1729–36.
31. Nelson CP, Hamby SE, Saleheen D, Hopewell JC, Zeng L, Assimes TL, et al.
Genetically determined height and coronary artery disease. N Engl J Med.
2015;372(17):1608–18.
32. Shimizu Y, Nakazato M, Sato S, Koyamatsu J, Yamanashi H, Nagayoshi
M, et al. Association between hemoglobin A1c and carotid
atherosclerosis in rural community-dwelling elderly Japanese men. J
Physiol Anthropol. 2015;34:16.
33. Shimizu Y, Nakazato M, Sekita T, Kadota K, Yamasaki H, Takamura N, et al.
Association of arterial stiffness and diabetes with triglycerides-to-HDL
cholesterol ratio for Japanese men: the Nagasaki Islands Study.
Atherosclerosis. 2013;228(2):491–5.
34. Kubo Y, Imaizumi T, Ando M, Nakatochi M, Yasuda Y, Honda H, et al.
Association between kidney function and genetic polymorphisms in
atherosclerotic and chronic kidney diseases: a cross-sectional study in
Japanese male workers. PLoS One. 2017;12(10):e0185476.
35. Shimizu Y, Sato S, Koyamatsu J, Yamanashi H, Nagayoshi M, Kadota K, et al.
Circulating CD34-positive cells, glomerular filtration rate and triglycerides in
relation to hypertension. Atherosclerosis. 2015;243(1):71–6.
36. Shimizu Y, Sato S, Koyamatsu J, Yamanashi H, Nagayoshi M, Kadota K, et al.
Associations between renal impairment and anemia in older, rural Japanese
men: the Nagasaki Island study. J Physiol Anthropol. 2014;33:7.
37. Shimizu Y, Maeda K, Imano H, Ohira T, Kitamura A, Kiyama M, et al. Chronic
kidney disease and drinking status in relation to risks of stroke and its
subtypes: the Circulatory Risk in Communities Study (CIRCS). Stroke. 2011;
42(9):2531–7.
38. Lindemann S, Krӓmer B, Seizer P, Gawaz M. Platelets, inflammation and
atherosclerosis. J Thromb Haemost. 2007;5:203–11.
39. Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key
elements of proinflammatory signalling. Semin Immunol. 2000;12(1):85–98.
40. Schattner M. Role of NF-κB pathway on platelet activation. Circ Res. 2013;
113(9):e92.
41. Ahmad KA, Yuan Yuan D, Nawaz W, Ze H, Zhuo CX, Talal B, et al.
Antioxidant therapy for management of oxidative stress induced
hypertension. Free Radic Res. 2017;51(4):428–38.
42. Shimizu Y, Yoshimine H, Nagayoshi M, Kadota K, Takahashi K, Izumino K, et
al. Height correlates with dyslipidemia in non-overweight middle-aged
Japanese men. J Physiol Anthropol. 2016;35(1):29.
Shimizu et al. Environmental Health and Preventive Medicine           (2019) 24:26 Page 8 of 8
